Central serous chorioretinopathy and the sclera: what we have learned so far

被引:4
|
作者
Koizumi, Hideki [1 ]
Imanaga, Naoya [1 ]
Terao, Nobuhiro [1 ]
机构
[1] Univ Ryukyus, Grad Sch Med, Dept Ophthalmol, 207 Uehara, Nishihara, Okinawa 9030215, Japan
关键词
Central serous chorioretinopathy; Pachychoroid; Sclera; Uveal effusion syndrome; Vortex vein; INDOCYANINE GREEN ANGIOGRAPHY; PHOTODYNAMIC THERAPY; VORTEX VEIN; THICKNESS; LOCULATION; FEATURES; EFFUSION; FLUID;
D O I
10.1007/s10384-024-01101-2
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Central serous chorioretinopathy (CSC) is a common disorder characterized by serous retinal detachment. Several studies using indocyanine green angiography (ICGA) have revealed that choroidal filling delay, choroidal vascular dilation, and choroidal vascular hyperpermeability are the characteristic findings of CSC. These ICGA findings confirm that choroidal circulatory disturbances are the primary factors in the pathogenesis of CSC. With advancements in optical coherence tomography (OCT), choroidal thickness has been found to be significantly greater in eyes with CSC than in normal eyes. Dilated large choroidal vessels reportedly account for the thickened choroid in eyes with CSC. Although many possible mechanisms and risk factors have been suggested, the pathophysiologic features of choroidal circulatory disturbances and choroidal thickening in eyes with CSC have not yet been fully elucidated. Recently, using anterior segment OCT, we proposed that the sclera may induce choroidal circulatory disturbances since CSC eyes have significantly thicker sclera than do normal eyes. This review summarizes updated information on the close relationship between CSC pathogenesis and the sclera.
引用
收藏
页码:419 / 428
页数:10
相关论文
共 50 条
  • [31] Tau Imaging in Parkinsonism: What Have We Learned So Far?
    Whitwell, Jennifer L.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2018, 5 (02): : 118 - 130
  • [32] Treatment of tendinopathy in the foot - what have we learned so far?
    Schramme, M.
    EQUINE VETERINARY EDUCATION, 2018, 30 (10) : 545 - 548
  • [33] Stress memory in crops: what we have learned so far
    Pissolato, Maria D.
    Martins, Tamires S.
    Fajardo, Yutcelia C. G.
    Souza, Gustavo M.
    Machado, Eduardo C.
    Ribeiro, Rafael V.
    THEORETICAL AND EXPERIMENTAL PLANT PHYSIOLOGY, 2024, 36 (03): : 535 - 565
  • [34] Income inequality and health: What have we learned so far?
    Subramanian, SV
    Kawachi, I
    EPIDEMIOLOGIC REVIEWS, 2004, 26 : 78 - 91
  • [35] Prophages and bacterial genomics: what have we learned so far?
    Casjens, S
    MOLECULAR MICROBIOLOGY, 2003, 49 (02) : 277 - 300
  • [36] Brain tumor immunotherapy: what have we learned so far?
    Van Gool, Stefaan Willy
    FRONTIERS IN ONCOLOGY, 2015, 5
  • [37] The hypocretins and the reward function: what have we learned so far?
    Boutrel, Benjamin
    Steiner, Nadia
    Halfon, Olivier
    FRONTIERS IN BEHAVIORAL NEUROSCIENCE, 2013, 7
  • [38] Immunotherapy in colorectal cancer: What have we learned so far?
    Sanchez-Castanon, Maria
    Er, Tze-Kiong
    Bujanda, Luis
    Herreros-Villanueva, Marta
    CLINICA CHIMICA ACTA, 2016, 460 : 78 - 87
  • [39] Sperm DNA fragmentation: What have we learned so far?
    Xie, Philip
    Cheung, Stephanie
    Kocur, Olena M.
    Rosenwaks, Zev
    Palermo, Gianpiero D.
    FERTILITY AND STERILITY, 2021, 116 (06) : 1491 - 1491
  • [40] CEREBRAL BYPASS PROCEDURES - WHAT HAVE WE LEARNED SO FAR
    HIRSH, LF
    ROMY, M
    POSTGRADUATE MEDICINE, 1983, 73 (06) : 199 - &